Latest News & Features
Big Pharma
UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit. 16 May 2018
Americas
Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical. 16 May 2018
Americas
Dechert has added two new partners to its IP practice in the US. 15 May 2018
Asia-Pacific
Canadian generics maker Apotex and India-based Strides Shasun will merge their Australian operations in a bid to create the leading player in the Australian generics pharmaceutical market. 15 May 2018
Americas
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision to invalidate a patent after a coalition formed by Kyle Bass requested a review. 15 May 2018
Americas
Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week. 15 May 2018
Big Pharma
Kirkland & Ellis has hired Nicola Dagg, the former head of Allen & Overy’s global IP practice, as a partner in the firm’s London office. 14 May 2018
Americas
The US Court of Appeals for the Federal Circuit has affirmed the dismissal of a clash between a non-profit organisation and Gilead over patents covering HIV drugs. 14 May 2018
Americas
Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme. 11 May 2018
Asia-Pacific
AstraZeneca has agreed to sell its rights to Seroquel (quetiapine fumarate) and Seroquel XR to China-based pharmaceutical company Luye Pharma Group for $538 million. 10 May 2018